These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8198968)

  • 1. Tumorigenicity of a combination of psoriasis therapies.
    Phillips DH; Alldrick AJ
    Br J Cancer; 1994 Jun; 69(6):1043-5. PubMed ID: 8198968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
    Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tar and dithranol on fibrinolysis in treatment of psoriasis].
    Arenberger P; Buchtová L
    Dermatol Monatsschr; 1990; 176(11):699-700. PubMed ID: 2083610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
    Schulze HJ; Schauder S; Mahrle G; Steigleder GK
    J Am Acad Dermatol; 1987 Jul; 17(1):19-24. PubMed ID: 3611453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin tumor initiating activity of therapeutic crude coal tar as compared to other polycyclic aromatic hydrocarbons in SENCAR mice.
    Mukhtar H; Das M; Bickers DR
    Cancer Lett; 1986 May; 31(2):147-51. PubMed ID: 3697959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
    Schauder S; Mahrle G
    Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benzo(a)pyrene and the carcinogenic effect of coal tar].
    Turusov VS; Kosoĭ KKh; Parfenov IuD
    Vopr Onkol; 1987; 33(10):62-7. PubMed ID: 3686910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay.
    Culp SJ; Gaylor DW; Sheldon WG; Goldstein LS; Beland FA
    Carcinogenesis; 1998 Jan; 19(1):117-24. PubMed ID: 9472702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
    Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA
    Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis symposium. Topical therapy.
    Menter A
    Semin Dermatol; 1992 Dec; 11(4 Suppl 1):5-10. PubMed ID: 1337263
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of DNA adduct formation in mice fed coal tar or benzo[a]pyrene.
    Culp SJ; Beland FA
    Carcinogenesis; 1994 Feb; 15(2):247-52. PubMed ID: 8313515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis.
    Marston CP; Pereira C; Ferguson J; Fischer K; Hedstrom O; Dashwood WM; Baird WM
    Carcinogenesis; 2001 Jul; 22(7):1077-86. PubMed ID: 11408352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies.
    Endzweig-Gribetz CH; Brady C; Lynde C; Sibbald D; Lebwohl M
    J Cutan Med Surg; 2002; 6(3 Suppl):12-6. PubMed ID: 11976987
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical agents for the treatment of psoriasis, past, present and future.
    Tremblay JF; Bissonnette R
    J Cutan Med Surg; 2002; 6(3 Suppl):8-11. PubMed ID: 11976984
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar.
    Schoket B; Horkay I; Kósa A; Páldeák L; Hewer A; Grover PL; Phillips DH
    J Invest Dermatol; 1990 Feb; 94(2):241-6. PubMed ID: 2299199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To BaP or not to BaP? That is the question.
    Goldstein LS
    Environ Health Perspect; 2001 Aug; 109(8):A356-7. PubMed ID: 11564626
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-contact modification of the Ingram regime.
    Ryatt KS; Statham BN; Rowell NR
    Br J Dermatol; 1984 Oct; 111(4):455-9. PubMed ID: 6487547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent bioassay results on coal tars and benzo(a)pyrene: implications for risk assessment.
    Gaylor DW; Moolgavkar S; Krewski D; Goldstein LS
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):178-9. PubMed ID: 9927566
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-producing activity of dithranol (anthralin) and two of its 10-acyl analogs in the dorsal skin of female NMRI mice.
    Männistö PT; Vaissi L; Mustakallio KK; Viluksela M; Kosma VM; Collan Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):255-60. PubMed ID: 6423812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of adverse effects associated with topical treatments for psoriasis.
    Bruner CR; Feldman SR; Ventrapragada M; Fleischer AB
    Dermatol Online J; 2003 Feb; 9(1):2. PubMed ID: 12639460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.